| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.1701019 |
| P8608 | Fatcat ID | release_vgjxjrorejhuzbnhm4lvlwgece |
| P932 | PMC publication ID | 5765878 |
| P698 | PubMed publication ID | 29311384 |
| P50 | author | Suzanne Ostrand-Rosenberg | Q64683350 |
| P2093 | author name string | Catherine Fenselau | |
| P2860 | cites work | Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion | Q79441078 |
| Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells | Q80274418 | ||
| TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs | Q80284232 | ||
| Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response | Q80582229 | ||
| CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells | Q81598364 | ||
| Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses | Q88012863 | ||
| Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity | Q88035142 | ||
| Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice | Q93516113 | ||
| The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications | Q24605052 | ||
| Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Q26744395 | ||
| Regulation of tumor metastasis by myeloid-derived suppressor cells | Q27022125 | ||
| Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences | Q27027064 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells | Q28256749 | ||
| ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis | Q28386923 | ||
| The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment | Q28388630 | ||
| Coordinated regulation of myeloid cells by tumours | Q28395157 | ||
| Regulation of immune responses by L-arginine metabolism | Q29614284 | ||
| Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN | Q29619346 | ||
| Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. | Q33564156 | ||
| Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells | Q33567728 | ||
| Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine | Q33584867 | ||
| Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells | Q33604925 | ||
| Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells | Q33707270 | ||
| Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells | Q33816455 | ||
| Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells | Q33919954 | ||
| Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells | Q34060558 | ||
| Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils | Q34163579 | ||
| Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression | Q34168497 | ||
| The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors | Q34228171 | ||
| HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment | Q34243443 | ||
| Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway | Q34314210 | ||
| HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells | Q34353413 | ||
| Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors | Q34484057 | ||
| The terminology issue for myeloid-derived suppressor cells | Q42425163 | ||
| Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways | Q42493330 | ||
| Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab | Q44017442 | ||
| Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer | Q45344986 | ||
| Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function | Q46064256 | ||
| Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function | Q46492738 | ||
| Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. | Q46529900 | ||
| Granulocytic Myeloid-Derived Suppressor Cells Accumulate in Human Placenta and Polarize toward a Th2 Phenotype. | Q46617657 | ||
| Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells. | Q47100735 | ||
| Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular Vesicles. | Q47615254 | ||
| Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice | Q47910452 | ||
| The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production | Q48347565 | ||
| Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion | Q48769325 | ||
| Evaluation of Spectral Counting for Relative Quantitation of Proteoforms in Top-Down Proteomics | Q48950646 | ||
| High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells | Q49973501 | ||
| Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. | Q54164371 | ||
| Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. | Q54269192 | ||
| Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. | Q54421148 | ||
| Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
| Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 | ||
| Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine | Q60311223 | ||
| Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
| Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor | Q73219365 | ||
| Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer | Q73311980 | ||
| Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo | Q77620517 | ||
| Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function | Q34616226 | ||
| Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis | Q34616787 | ||
| Ubiquitinated proteins in exosomes secreted by myeloid-derived suppressor cells | Q34669523 | ||
| Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy | Q34810257 | ||
| Modulation of the antitumor immune response by complement | Q34838919 | ||
| GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells | Q34983887 | ||
| Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL | Q35029951 | ||
| Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity | Q35067909 | ||
| Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells | Q35067983 | ||
| Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model | Q35345202 | ||
| Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice | Q35370005 | ||
| Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression | Q35478848 | ||
| Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. | Q35553327 | ||
| Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice | Q35648172 | ||
| TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms | Q35814020 | ||
| IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. | Q36026855 | ||
| Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained | Q36186882 | ||
| Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer | Q36260673 | ||
| Transcriptional regulation of myeloid-derived suppressor cells | Q36322351 | ||
| TNF signaling drives myeloid-derived suppressor cell accumulation | Q36357903 | ||
| Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma | Q36403544 | ||
| A core of kinase-regulated interactomes defines the neoplastic MDSC lineage | Q36413721 | ||
| Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. | Q36432026 | ||
| Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells | Q36454468 | ||
| γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. | Q36473289 | ||
| Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells | Q36489379 | ||
| Exosomes and tumor-mediated immune suppression | Q36737920 | ||
| Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2. | Q36767546 | ||
| Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. | Q36963408 | ||
| Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. | Q36982546 | ||
| Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity | Q36996588 | ||
| Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells | Q37147482 | ||
| G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models | Q37149710 | ||
| Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis | Q37200858 | ||
| Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4 | Q37232937 | ||
| Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. | Q37317912 | ||
| Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. | Q37325176 | ||
| Induction of myeloid-derived suppressor cells by tumor exosomes | Q37375966 | ||
| Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. | Q37382352 | ||
| Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma | Q37496791 | ||
| Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes | Q37544847 | ||
| Exosomes from myeloid-derived suppressor cells carry biologically active proteins | Q37624283 | ||
| Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). | Q38006616 | ||
| Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology | Q38018279 | ||
| Protumor and antitumor functions of neutrophil granulocytes | Q38046098 | ||
| Immunomonitoring and prognostic relevance of neutrophils in clinical trials. | Q38080998 | ||
| History of myeloid-derived suppressor cells | Q38141522 | ||
| Myeloid-derived suppressor cell heterogeneity in human cancers | Q38223250 | ||
| Drafting the proteome landscape of myeloid-derived suppressor cells. | Q38592376 | ||
| Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells. | Q38805069 | ||
| Tumor-Derived Exosomes and Their Role in Cancer Progression | Q38818439 | ||
| RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis | Q38844181 | ||
| Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation | Q38969799 | ||
| Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression | Q39087629 | ||
| Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease | Q39146128 | ||
| Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms | Q39158003 | ||
| Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells | Q39237839 | ||
| Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. | Q39244686 | ||
| Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. | Q39770285 | ||
| Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
| Natural Suppressor (NS) Cells, Neonatal Tolerance, and Total Lymphoid Irradiation: Exploring Obscure Relationships | Q40097097 | ||
| Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study | Q40148008 | ||
| Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression | Q40338318 | ||
| Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis | Q40339595 | ||
| High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells | Q40519826 | ||
| Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. | Q40605195 | ||
| Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells. | Q41974388 | ||
| Suppression of cytotoxic T-cell generation by natural suppressor cells from mice with GVHD is partially reversed by indomethacin | Q42160714 | ||
| Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples | Q42219156 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 422-431 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment | |
| P478 | volume | 200 |
| Q90413936 | A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy |
| Q92769536 | A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer |
| Q60930257 | Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression |
| Q92577831 | Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients |
| Q61165112 | B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses |
| Q89996479 | Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2 |
| Q98629376 | Central nervous system (CNS) tumor cell heterogeneity contributes to differential platinum-based response in an in vitro 2D and 3D cell culture approach |
| Q57155814 | Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes |
| Q92541892 | Contribution of Angiogenesis to Inflammation and Cancer |
| Q90167003 | Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD |
| Q89621149 | Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma |
| Q96431185 | Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging |
| Q89820704 | Editorial: Myeloid Derived Suppressor Cells as Disease Modulators |
| Q64113924 | Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment |
| Q90348453 | Eosinophils can more than kill |
| Q90320106 | Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9 |
| Q94452375 | High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients |
| Q64066403 | IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury |
| Q93127613 | Identification of an Immunosuppressive Cell Population during Classical Swine Fever Virus Infection and Its Role in Viral Persistence in the Host |
| Q93189340 | Immune regulation and anti-cancer activity by lipid inflammatory mediators |
| Q64234120 | Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency |
| Q64890074 | Immunostimulatory functions of adoptively transferred MDSCs in experimental blunt chest trauma. |
| Q92503954 | Immunotherapy in breast cancer |
| Q89393186 | Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist |
| Q98177692 | Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy |
| Q92776826 | Japanese Kampo Medicine Juzentaihoto Enhances Antitumor Immunity in CD1d-/- Mice Lacking NKT Cells |
| Q88870841 | Monocytic myeloid-derived suppressor cells generated from rhesus macaque bone marrow enrich for regulatory T cells |
| Q92879135 | Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression |
| Q97075394 | Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages |
| Q55295587 | Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors. |
| Q98465646 | Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation |
| Q92052235 | Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer |
| Q64954875 | Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity. |
| Q62271302 | Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer |
| Q88669747 | Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies |
| Q90401202 | Neutrophils as Suppressors of T Cell Proliferation: Does Age Matter? |
| Q94467230 | New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometry |
| Q88678430 | Obesity as an immune-modifying factor in cancer immunotherapy |
| Q92077676 | Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation |
| Q64079628 | Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets |
| Q92533671 | RNA Sequencing of the Tumor Microenvironment in Precision Cancer Immunotherapy |
| Q93196390 | Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal |
| Q92282692 | Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model |
| Q90007578 | Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment |
| Q92880866 | TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma |
| Q50133240 | The Cancer Immunotherapy Revolution: Mechanistic Insights |
| Q89924022 | The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer |
| Q89967090 | The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
| Q57166654 | The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy |
| Q98735532 | The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion |
| Q91621354 | The impact of psychosocial stress and stress management on immune responses in patients with cancer |
| Q90213618 | Top-Down Proteomic Characterization of Truncated Proteoforms |
| Q90239273 | Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer |
| Q98771756 | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy |
| Q92502928 | Tumour-associated neutrophils in patients with cancer |
| Q97644531 | Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss |
| Q98465701 | cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies |
| Q90364630 | β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells |
Search more.